The production of ROS (reactive oxygen species) by mammalian mitochondria is important because it underlies oxidative damage in many pathologies and contributes to retrograde redox signalling from the organelle to the cytosol and nucleus. Superoxide (O 2
INTRODUCTION
Mitochondria are an important source of ROS (reactive oxygen species) within most mammalian cells [1] [2] [3] [4] [5] [6] [7] [8] . This ROS production contributes to mitochondrial damage in a range of pathologies and is also important in redox signalling from the organelle to the rest of the cell [3, 9] . Consequently, knowledge of how mitochondria produce ROS is vital to understand a range of currently important biomedical topics ( Figure 1 ). The first report that the respiratory chain produced ROS came in 1966 [10] , followed by the pioneering work of Chance and colleagues who showed that isolated mitochondria produce H 2 O 2 [4, 11, 12] . Later, it was confirmed that this H 2 O 2 arose from the dismutation of superoxide (O 2 •− ) generated within mitochondria [13, 14] . The parallel discovery that mitochondria contain their own SOD (superoxide dismutase), MnSOD, confirmed the biological significance of mitochondrial O 2
•− production [15] . Since then, a huge literature has developed on the sources and consequences of mitochondrial ROS production, which I will not attempt to cover systematically. Instead, I shall develop a consensus about how mitochondria produce ROS and indicate current uncertainties and future issues to be addressed. The focus of the present review is the production of the proximal mitochondrial ROS, O 2 •− , in the mitochondrial matrix by the core metabolic machinery present in the mitochondrial inner membrane and matrix. Other potentially important ROS sources associated with the mitochondrial outer membrane or intermembrane space will not be considered [1, 5] . The aim is to provide a useful resource for those working on mitochondrial ROS production, to facilitate the design and interpretation of experiments, and to stimulate new approaches.
O 2 •− , THE PROXIMAL MITOCHONDRIAL ROS
Within mitochondria, O 2 •− is produced by the one-electron reduction of O 2 . Therefore it is the kinetic and thermodynamic factors underlying the interaction of potential one-electron donors with O 2 that control mitochondrial ROS production. Having two unpaired electrons in antibonding orbitals with parallel spins makes ground-state O 2 accept one electron at a time [16] . The standard reduction potential for the transfer of an electron to O 2 to form O 2
•− is −160 mV at pH 7 [16] , for a standard state of 1 M O 2 . As the pK a of O 2
•− is 4.7 [16] , this standard reduction potential is invariant across most biological pH values. The actual reduction potential that determines the thermodynamic tendency of O 2 to form O 2
•− , E h , will vary with the relative concentrations of O 2 and O 2
•− :
E h (mV) = −160 + 61.5 log 10 [
The [O 2 ] in air-saturated aqueous buffer at 37
• C is approx. 200 μM [17] ; however, mitochondria in vivo are exposed to a considerably lower [O 2 ] that varies with tissue and physiological state [18] . This occurs because the mitochondrial [O 2 ] in vivo is largely set by the extracellular [O 2 ] in the tissue, which is itself determined by local O 2 delivery and consumption [18] . In addition, [O 2 ] decreases on going from the extracellular Figure 1 Overview of mitochondrial ROS production ROS production by mitochondria can lead to oxidative damage to mitochondrial proteins, membranes and DNA, impairing the ability of mitochondria to synthesize ATP and to carry out their wide range of metabolic functions, including the tricarboxylic acid cycle, fatty acid oxidation, the urea cycle, amino acid metabolism, haem synthesis and FeS centre assembly that are central to the normal operation of most cells. Mitochondrial oxidative damage can also increase the tendency of mitochondria to release intermembrane space proteins such as cytochrome c (cyt c) to the cytosol by mitochondrial outer membrane permeabilization (MOMP) and thereby activate the cell's apoptotic machinery. In addition, mitochondrial ROS production leads to induction of the mitochondrial permeability transition pore (PTP), which renders the inner membrane permeable to small molecules in situations such as ischaemia/reperfusion injury. Consequently, it is unsurprising that mitochondrial oxidative damage contributes to a wide range of pathologies. In addition, mitochondrial ROS may act as a modulatable redox signal, reversibly affecting the activity of a range of functions in the mitochondria, cytosol and nucleus.
environment to the mitochondrion, owing to O 2 consumption by cytochrome oxidase [18, 19] . Plausible estimates for the mitochondrial [O 2 ] in vivo are in the range 3-30 μM [2] . The steadystate intramitochondrial [O 2
•− ] is difficult to measure accurately, but it is likely to be very low because of micromolar concentrations of MnSOD in the mitochondrial matrix (e.g. 11 μM MnSOD in rat liver mitochondria [20] [21, 22] . Tentative estimates for [O 2
•− ] within the mitochondrial matrix are in the range 10-200 pM [4, 5] •− . For a given enzyme or protein (E), the rate of O 2
•− production is:
This can be extended to consider several potential electrondonor sites within mitochondria, and also to take into account multiple electron donor sites within a single protein:
The concentration of the enzyme responsible for O 2 •− production, [E], will vary with organism, tissue, state, age or hormonal status, and may underlie many of the changes in maximum ROS production capacity between tissues [23] ; for example, complex I content may explain the different maximum capacities of pigeon and rat heart mitochondria [24] .
As the apparent K m of cytochrome oxidase for O 2 is very low (<1 μM [25] •− production [36] [37] [38] . Probably the most important factor that determines O 2
•− production by mitochondria is the proportion, P R , of a given electron carrier that is reactive with O 2 to form O 2
•− , as P R responds rapidly to a range of biological situations. The relationship between P R and the overall reduction state of an electron carrier group in a protein may be complicated, as the redox form that donates an electron to O 2 is not necessarily fully reduced. Instead, a partially reduced form, such as a semiquinone, that can respond to the cumulative reduction of an electron carrier system may be the critical electron donor. For any electron carrier, P R will be affected by changes in the carrier's E m and in its rate of electron supply and release, all of which can be altered by inhibition, damage, mutation or post-translational modification to protein complexes distal or proximal to the site, or to the protein itself. Many other factors can have an impact on P R by affecting these parameters, with changes in p (protonmotive force) likely to be particularly important as it significantly affects the P R of electron carriers and it varies rapidly in response to changes in mitochondrial ATP synthesis.
The final factor affecting the rate of O 2 •− production by electron carriers within proteins is the second-order rate constant (k E ) of their reaction with O 2 . The reaction between protein-bound electron carriers and O 2 to form O 2
•− is generally thought to occur through an outer-sphere mechanism described by the Marcus theory [39, 40] . In this mechanism, an electron tunnels from the electron donor to O 2 , and the rate is very dependent on the distance between O 2 and the electron donor [39, 40] . This is similar to electron movement down the respiratory chain which occurs by electron tunnelling from carrier to carrier, with a maximum distance of approx. 14 Å (1 Å = 0.1 nm) between each carrier for effective tunnelling to occur [41] . Similar distance constraints probably apply to the reaction of protein-bound electron carriers in the respiratory chain with O 2 to form O 2
•− , with the bulk of the protein acting as an insulator to keep O 2 at a safe distance from the carriers and thereby minimize O 2
•− production [41] . Consequently, O 2
•− production will probably occur at sites where O 2 can approach closely to electron carriers, such as at active sites exposed to the aqueous phase or to the membrane core. •− may be a side reaction, the rate varies over five orders of magnitude [43] . Even so, the rate of reduction of O 2 by the reduced FMN of complex I to form O 2
•− · min −1 [28] , corresponding to a second-order rate constant of ∼ 10 3 M −1 · s −1 . Thus the second-order rate constants (k E ) for O 2 •− production as a side reaction by protein-bound electron carriers can be rapid, although it is likely to vary markedly with the environment of the electron donor and its accessibility to O 2 . Therefore alterations to a protein that enabled O 2 to approach more closely to the electron carrier, such as by damage, mutation, post-translational modification, conformational change or quaternary interactions, could lead to dramatic changes in the rate of O 2
•− production, and potentially play a regulatory function. Such factors determining the second-order rate constant for the reaction of O 2 with protein electron carriers could determine mitochondrial O 2
•− production, but little is known about how k E may be varied by different enzymes within mitochondria.
Figure 2 Measurement of H 2 O 2 production by isolated mitochondria
The production of O 2
•− within the mitochondrial matrix, intermembrane space and outer membrane leads to the formation of H 2 O 2 from SOD-catalysed dismutation. Some O 2
•− can react directly with nitric oxide (NO • ) to form peroxynitrite (ONOO − ). There are also sources outside mitochondria that produce H 2 O 2 directly. The H 2 O 2 efflux from mitochondria can be measured following reaction with a non-fluorescent substrate such as Amplex Red in conjunction with horseradish peroxidase (HRP) to form a fluorescent product, resorufin. Within mitochondria H 2 O 2 is degraded by glutathione peroxidases (GPx) or peroxiredoxins (Prx) which depend on glutathione (GSH) and thioredoxin-2 (Trx) for their reduction respectively. Glutathione disulfide (GSSG) is reduced back to GSH by glutathione reductase (GR). Trx is reduced by thioredoxin reductase-2 (TrxR). Both enzymes receive reducing equivalents from the NADPH pool, which is kept reduced by the p-dependent transhydrogenase (TH), and by isocitrate dehydrogenase (ICDH). Note that many mitochondrial preparations, particularly those from the liver, contain large amounts of catalase contamination. The effects of such extramitochondrial H 2 O 2 sinks are not indicated here as they are usually accounted for by appropriate H 2 O 2 calibration curves in the presence of mitochondria. ox, oxidized; red, reduced. An animated version of this Figure can be seen at http://www.BiochemJ.org/bj/417/0001/bj4170001add.htm.
within isolated mitochondria under conditions that mimic those that may arise in vivo under physiological or pathological conditions. A constraint of using isolated mitochondria is that the system is complicated and difficult to manipulate. In particular, the direct measurement of O 2
•− within mitochondria is challenging due to its rapid dismutation in the presence of
, which leads to very low steady-state matrix [O 2
•− ] and competes with O 2 •− detection systems [44] . {The spontaneous dismutation of O 2
•− (k ≈ 10 6 [16] ) is less important because it is second-order with respect to [O 2
•− ], which is very low in the presence of MnSOD.} Studies have been carried out on O 2
•− production by mitochondria lacking MnSOD [44] , but there is always the concern that the absence of MnSOD may decrease the flux of O 2
•− by allowing the back reaction between O 2
•− and the electron donor [21, 22] , as well as having the potential to damage the system [45, 46] . The use of O 2
•− -sensitive dyes such as hydroethidine and MitoSOX TM [47] [48] [49] [50] , measurement of the reaction of O 2 •− with compounds to form chemiluminescent products [44, 51] , spin trapping [52] or measurement of the inactivation rate of aconitase [53] do provide useful information on mitochondrial O 2
•− production. Even so, measurement is challenging, and the quantification of O 2
•− production by isolated mitochondria is not done routinely.
In contrast with the difficulties of assessing O 2
•− flux can be readily measured in isolated mitochondria following its dismutation to H 2 O 2 by MnSOD and subsequent diffusion from the mitochondria [11, 54, 55] . There are a number of ways of assaying this H 2 O 2 , but typically this is now done by measuring the oxidation of a non-fluorescent dye by H 2 O 2 in conjunction with a peroxidase to form a fluorescent product ( Figure 2 ) [11, [55] [56] [57] . Although such assays are reliable, sensitive and robust, there are a number of issues to be considered in interpreting these data and in extrapolating from isolated mitochondria to the in vivo situation. First, not all O 2
•− is necessarily converted into H 2 O 2 in vivo, as some O 2
•− could react with other electron acceptors or with NO
• within mitochondria [58, 59] . Although the extent of these reactions is not known, situations may arise where they are significant, particularly as physiological levels of NO
• can react very rapidly with O 2 [58, 59] . Secondly, measurement of H 2 O 2 efflux from mitochondria will also be affected by H 2 O 2 produced in the intermembrane space or outer membrane, which can be significant under some conditions [1, 52, 60] . Thirdly, and most importantly, not all H 2 O 2 produced within the mitochondrial matrix will survive to efflux from the mitochondria, owing to matrix peroxidases that consume H 2 O 2 [1, [61] [62] [63] . These include peroxiredoxins 3 and 5 [64] , catalase [65, 66] and glutathione peroxidases 1 and 4 [67] , with the peroxiredoxins probably of the greatest significance [64] . Thus the rate of matrix O 2
•− formation is the sum of the H 2 O 2 measured effluxing from the mitochondria, the O 2
•− sinks, the rate of H 2 O 2 degradation to water, minus H 2 O 2 production from outside mitochondria (eqn 4) (Figure 2 ):
Consequently, there is a threshold of intramitochondrial O 2
•− formation before it exceeds scavenging by O 2 •− sinks and peroxidases, and generates sufficient H 2 O 2 to be measured externally [1, 61] . A corollary is that there may be significant O 2
•− formation within mitochondria that goes undetected, which is supported by the finding that H 2 O 2 efflux from mitochondria increases on inhibition of peroxidases [1, 68] . An interesting extension is that the activity of intramitochondrial peroxidases such as peroxiredoxins is decreased on exposure to H 2 O 2 [69] [70] [71] , and thus the mitochondrial H 2 O 2 -degradation rate may vary considerably with condition and history of the organelle. Consistent with this, exposure of mitochondria to H 2 O 2 leads to greater H 2 O 2 efflux [27] , and may be one way in which H 2 O 2 efflux from mitochondria is regulated by a feed-forward cycle of ROSinduced ROS efflux. A related factor is that many mitochondrial manipulations affect the activity of H 2 O 2 -degradation systems, which are linked to the GSH/GSSG ratio through glutathione peroxidases [67] and to the thioredoxin-2 oxidized/reduced ratio through peroxiredoxins [62, 63, 68, 72, 73] . These in turn are affected by the NADPH/NADP + ratio which is set by the activity of the transhydrogenase and of NADP + -dependent isocitrate dehydrogenase [74, 75] (Figure 3 ). The first mode occurs when there is a high NADH/NAD + ratio in the matrix [27, 28] . The second mode is when there is a highly reduced CoQ (coenzyme Q) pool, in conjunction with a maximal p and no ATP synthesis [57, 78, 79] . The third mode of mitochondrial operation is when the mitochondria are working normally making ATP (i.e. they are in, or close to, state 3), or using the p for other functions such as thermogenesis. In this third mode of operation, H 2 O 2 efflux from mitochondria is negligible compared with modes 1 or 2. Our next focus is to understand in detail the sites and mechanisms of O 2
•− production under these three modes of mitochondrial operation and thereby infer where and how O 2
•− is produced in vivo.
Sites of O 2
•− production within isolated mitochondria
Complex I
Mammalian complex I is the entry point for electrons from NADH into the respiratory chain and is a ∼ 1 MDa complex comprising 45 polypeptides [80, 81] . An FMN cofactor accepts electrons from NADH and passes them through a chain of seven FeS (ironsulfur) centres to the CoQ reduction site, with another FeS centre (N1a) close to the FMN, but not thought to be involved in electron transfer to CoQ [80, 81] . The structure of the water-soluble arm There are three modes of mitochondrial operation that are associated with O 2 •− production. In mode 1, the NADH pool is reduced, for example by damage to the respiratory chain, loss of cytochrome c during apoptosis or low ATP demand. This leads to a rate of O 2
•− formation at the FMN of complex I that is determined by the extent of FMN reduction which is in turn set by the NADH/NAD + ratio. Other sites such as αKGDH may also contribute. In mode 2, there is no ATP production and there is a high p and a reduced CoQ pool which leads to RET through complex I, producing large amounts of O 2
•− . In mode 3, mitochondria are actively making ATP and consequently have a lower p than in mode 2 and a more oxidized NADH pool than in mode 1. Under these conditions, the flux of O 2
•− within mitochondria is far lower than in modes 1 and 2, and the O 2
•− sources are unclear.
of complex I from Thermus thermophilus, which contains the FMN and the FeS centres, is known and is likely to be very similar to that in mammals [80] [81] [82] . However, the structure of the CoQ reduction site in the hydrophobic arm is not known and the mechanism of proton pumping by complex I is uncertain [80] [81] [82] . •− and that this generation is enhanced by the inhibitor rotenone which binds to the CoQ-binding site [84] . The mechanism of O 2
•− production by isolated complex I is now reasonably well understood [28, 85] . The isolated complex produces O 2
•− from the reaction of O 2 with the fully reduced FMN, and the proportion of the FMN that is fully reduced (P R ) is set by the NADH/NAD + ratio [28, 85] . This model explains why inhibition of complex I with rotenone increases O 2
•− production, as it will lead to a back up of electrons onto FMN which will produce O 2
•− [86, 87] . For complex I within intact mitochondria, the proportion of fully reduced FMN is thought to be set by the NADH/NAD + ratio, so inhibition of the respiratory chain by damage, mutation, ischaemia, loss of cytochrome c or by the build up of NADH due to low ATP demand and consequent low respiration rate will increase the NADH/NAD + ratio and lead to O 2
•− formation [27, 28, 57, [88] [89] [90] . In contrast, for most situations where mitochondria are respiring normally on NADH-linked substrates and the NADH/NAD + ratio is relatively low, only small amounts of O 2
•− are produced from complex I [87] . An elegant demonstration of the importance of an elevated NADH/NAD + ratio for O 2
•− production from complex I is that oxidation of the NADH pool in mammalian mitochondria by expression of a yeast NADH dehydrogenase decreases O 2
•− production [91] . The other mechanism by which complex I produces large amounts of O 2
•− is during RET (reverse electron transport) [7, 27, 87, 89] . RET occurs for mitochondria operating in mode 2 when electron supply reduces the CoQ pool, which in the presence of a significant p forces electrons back from CoQH 2 into complex I, and can reduce NAD + to NADH at the FMN site [92] . RET was first associated with H 2 O 2 production in SMPs respiring on succinate [83, 93] . Later, it was shown that isolated mitochondria respiring on succinate, also generate large amounts of O 2
•− from complex I by RET [94] . Since then it has become clear that there is extensive O 2
•− production by RET at complex I in isolated brain, heart, muscle and liver mitochondria under conditions of high p with electron supply to the CoQ pool from succinate, α-glycerophosphate or fatty acid oxidation [7, 24, 87, 89] . This O 2
•− production by RET is abolished by rotenone, confirming that it is due to electrons entering into complex I through the CoQ-binding site(s) [95] . Of particular note, the dependence of RET-associated O 2
•− production on p is very steep and is abolished completely by a small decrease in p [79, 87] , presumably by decreasing the thermodynamic driving force pushing electrons to the O 2
•− -producing site(s) within complex I. Intriguingly, O 2
•− production by complex I is more sensitive to changes in the pH (pH gradient) component of the p, than to the ψ (membrane potential) component [79, 96] . The complex I site producing O 2 •− during RET is unclear [85, 97] . The simplest possibility is that RET forces electrons right back through complex I to the FMN, and that the site of O 2
•− production is the same during RET as it is for O 2
•− production from the reduced FMN in response to an elevated NADH/NAD + ratio [85, 89] . Consistent with this, the flavin inhibitor DPI (diphenyleneiodonium) blocks RET-associated O 2
•− production by complex I [89] ; however, this does not confirm the involvement of the FMN site, as DPI has other interactions with mitochondria [97] . Furthermore, disruption of the CoQbinding site in complex I under conditions where there was a high pH led to far more extensive O 2 •− production than reduction of FMN alone, suggesting a role for the CoQ-binding site in RET O 2
•− production [95] . In addition, there is not a unique relationship between the mitochondrial NADH/NAD + ratio and O 2
•− production by complex I under different conditions [98] . This suggests that O 2
•− production from complex I may occur both by RET and from the reduction of FMN by the NADH pool simultaneously, and that most of the O 2
•− generated during RET is not produced at the FMN. If O 2
•− is not produced at FMN during RET, then the focus shifts to the CoQ-binding site, where two electrons are passed from the N2 FeS centre to CoQ, reducing it to CoQH 2 , while pumping four H + across the mitochondrial inner membrane by an unknown mechanism. The intriguing pH-and pH-dependence of O 2
•− production during RET [79] may suggest that critical semiquinones and semiquinolates are formed during proton pumping that react directly with O 2 to form O 2
•− [57, 88, 95] . However, our lack of knowledge of the full structure of complex I and its exact mechanism of proton pumping hampers progress. More positively, it may be that investigating the mechanism of O 2
•− production [95] , and the unusual interaction of complex I with electron acceptors during RET [44] , may shed light on the mechanism of proton pumping by complex I.
To summarize, complex I produces large amounts of O 2 •− by two mechanisms: when the matrix NADH/NAD + ratio is high, leading to a reduced FMN site on complex I, and when electron donation to the CoQ pool is coupled with a high p leading to RET (Figure 4) . Although the site of O 2
•− production during RET is not known, the rate of O 2
•− production under RET seems to be the highest that can occur in mitochondria [71, 79, 95] .
Complex III
Complex III funnels electrons from the CoQ pool to cytochrome c. The monomer is ∼ 240 kDa and comprises 11 polypeptides, three haems and an FeS centre, and it interacts transiently with CoQ during the Q-cycle at the Q i and Q o sites [99] . Complex III has for a long time been regarded as a source of O 2
•− within mitochondria [84, 100] . When supplied with CoQH 2 and when the Q i site is inhibited by antimycin, complex III produces large amounts of O 2
•− from the reaction of O 2 with a ubisemiquinone bound to the Q o site [84, 89, [100] [101] [102] [103] . This O 2
•− is released from complex III to both sides of the inner membrane [24, 27, 52, 104] . However, in the absence of antimycin, the Q o site ubisemiquinone is not stabilized and O 2
•− production by complex III is low [105] . Inhibition of respiration at points distal to complex III with cyanide or by loss of cytochrome c does not increase O 2
•− production by complex III [100] , therefore reduction of the CoQ pool is not sufficient to generate O 2
•− at complex III. It may be that high p stabilizes the Q o site ubisemiquinone; however, the very high production of O 2
•−
by complex I during RET in the presence of succinate is abolished completely by rotenone [87, 95] . Under these conditions, there is a large p and a reduced CoQ pool, suggesting that the maximal O 2
•− production by uninhibited complex III is negligible compared with that by complex I during RET. However, it is possible that, for mitochondria operating in mode 3, when O 2
Figure 4 Production of O 2
•− by complex I
The cartoon of complex I is a chimaera modelled on the hydrophobic arm of Yarrowia lipolytica obtained by electron microscopy [132] and the crystal structure of the hydrophilic arm from Thermus thermophilus [82] . Under these conditions, factors that affect the stability of the ubisemiquinone radical in the Q o site, such as loss of cytochrome c or changes in p or in the redox state of the CoQ and cytochrome c pools, may modulate O 2
•− production. Therefore, although complex III can be induced to produce O 2
•− with the inhibitor antimycin, its production in mitochondria under physiological conditions is far lower and is negligible compared with the maximum rates of O 2
•− production from complex I.
Other sites of O 2 •− production within mitochondria
Many other sites within mitochondria may also produce O 2 •− or H 2 O 2 . It is convenient to divide most of these into sites that interact with the matrix NADH pool and those that are connected to the CoQ pool within the inner membrane.
When respiratory chain activity is low, or when there is RET, the NADH/NAD + ratio will increase and this may lead to O 2
•− production at other sites connected to the NADH pool, in addition to complex I. When complex I is inhibited with rotenone, there is a reduced NADH pool and ROS production from complex I, but addition of 2-oxoglutarate (α-ketoglutarate) as a substrate increases ROS production further, suggesting that the combination of 2-oxoglutarate with a reduced NADH pool may lead to significant ROS production from αKGDH [2-oxoglutarate dehydrogenase (α-ketoglutarate dehydrogenase)] [7, [106] [107] [108] . One component of αKGDH is dihydrolipoamide dehydrogenase, which contains a flavin that can produce ROS when its electron acceptor NAD + is limiting [7, [106] [107] [108] . Decreasing the expression of dihydrolipoamide dehydrogenase in mouse fibroblasts decreased O 2
•− production in mitochondria isolated from these cells [7, [106] [107] [108] . A similar situation may exist for other enzymes that contain dihydrolipoamide dehydrogenase, such as pyruvate dehydrogenase, but their capacity for O 2
•− production seems to be less than that of αKGDH [106] . Therefore, under conditions of high NADH/NAD + ratio, not only complex I, but also αKGDH, and perhaps other enzymes linked to the NADH pool, may contribute to O 2
•− production in a manner that depends on the mitochondrial substrates. It may be that when mitochondria are operating in mode 3 and are actively making ATP, O 2
•− production from complex I is negligible and the contribution from sites such as αKGDH is proportionally more significant [106] .
Many potential sites of O 2 •− production interact with the CoQ pool. Fatty acid oxidation in the matrix reduces ETF (electron transfer flavoprotein) which passes its electrons to CoQ via ETF:CoQ oxidoreductase on the matrix surface of the inner membrane [109] . Oxidation of palmitoyl-CoA by mitochondria leads to H 2 O 2 production [12, 90] , primarily from RET at complex I; however, ETF:CoQ reductase may itself produce ROS [24] . Dihydroorotate dehydrogenase on the outer surface of the inner membrane catalyses oxidation of dihydro-orotate to orotate with reduction of CoQ, and dihydro-orotate oxidation is associated with mitochondrial O 2
•− production [110] ; however, it is uncertain whether O 2
•− is produced by dihydro-orotate dehydrogenase itself. On the outer surface of the inner membrane, αGPDH (α-glycerophosphate dehydrogenase) takes electrons from α-glycerophosphate to CoQ [111] [112] [113] . In brown adipose tissue mitochondria [112] , and in Drosophila mitochondria [114] , oxidation of α-glycerophosphate is associated with ROS production, much of this due to RET from complex I, although some is produced from αGPDH itself on the outer surface of the mitochondrial inner membrane [113] . However, the physiological significance of this is unclear, as αGPDH is expressed at relatively low levels in most mammalian tissues [111, 112] , although it may be important in the brain [113] . Complex II oxidizes succinate passing electrons to CoQ, but, although the damaged or mutated complex can produce ROS [101, 115] , it seems that all O 2 •− production during succinate oxidation arises from complex I by RET. Therefore the activity of a number of CoQ-linked enzymes is associated with increased ROS production, primarily by favouring RET at complex I, but, in some cases, they may produce ROS directly themselves.
In addition to the sites discussed above, there are many other mitochondrial enzymes that can be induced to produce O 2
•− or H 2 O 2 . Some of these are not connected to the NADH or CoQ pools, such as the adrenodoxin reductase/adrenodoxin/cytochrome P 450 system in the mitochondrial matrix that receives electrons from the NADPH pool [116, 117] . Therefore it is probable that many other sites of mitochondrial O 2
•− production remain to be discovered, but whether they make a quantitatively significant contribution to mitochondrial ROS production under physiological conditions is unclear [1] .
Overview of O 2
•− production by isolated mitochondria
It is possible to draw some tentative conclusions about O 2
•− production by isolated mitochondria. Two modes of operation lead mitochondria to produce large amounts of O 2 •− : mode 1, when there is a build up of NADH, and mode 2, when there is a large p and a reduced CoQ pool (Figure 3) . In both modes, the predominant site of O 2
•− production is complex I, in keeping with a growing view that complex I is the major source of O 2
•− within mitochondria in vivo [1, 7, 85, 118] . Even so, the accumulation of NADH that occurs in modes 1 and 2 may lead to O 2
•− production from other sites such as αKGDH. The mechanisms of O 2
•− production from complex I in the two modes are quite distinct, being by reduction of FMN by NADH in mode 1 and by RET in mode 2. Of course, in some situations, both mode 1 and mode 2 may operate simultaneously when a build up of NADH and CoQ coincides with a high p.
The mode 1 production of O 2 •− probably occurs in vivo under conditions where damage to the respiratory chain, slow respiration or ischaemia leads to a build up of NADH. This may occur during cytochrome c release in apoptosis and following inhibition of respiration at cytochrome oxidase by NO
• . Treatments that oxidize the NADH pool, such as overexpressing NADH oxidases, should decrease the production of O 2
•− in mode 1, while rotenone and other respiratory inhibitors should increase it (antimycin would not be diagnostic here as it will increase O 2
•− production at complex III). Whether mode 2 O 2
•− production occurs in cultured cells or in vivo is not known. If it does, it would be associated with a high p and a reduced CoQ pool, and will be very sensitive to mild uncoupling and to inhibition by rotenone. The generation of O 2
•− by both modes 1 and 2 will be decreased by mild uncoupling, perhaps suggesting that the physiological function of uncoupling proteins-2 and -3 is to modulate mitochondrial O 2
•− production [118] . Mode 3 occurs when mitochondria are synthesizing ATP or utilizing p for other functions. Under these conditions, the lowered p and the oxidized NADH pool prevent O 2
•− production by RET and greatly decrease O 2
•− production at the FMN of complex I, making H 2 O 2 efflux from mitochondria negligible compared with modes 1 or 2 (e.g. [4, 78, 89, 119] ). However, there may still be O 2
•− production within mitochondria operating in mode 3 that is below the threshold consumed by mitochondrial peroxidases (eqn 4) [68] . Although the sites of this putative O 2
•− production in mode 3 are unclear, complex I, complex III and matrix enzymes such as αKGDH could all contribute. A further complication is that in vivo substrate supply to the respiratory chain is stringently regulated by factors such as dietary and hormonal status, leading to alterations in the steadystate reduction potential of mitochondrial electron carriers. As mitochondria in vivo probably spend much of their time synthesizing ATP, this mode of O 2
•− production may account for most of the overall exposure of mitochondria to O 2
•− . Thus, even though the rate of O 2
•− production in mode 3 is relatively low and the sources are poorly understood, it may turn out to be the mode of greatest biological importance and be responsible for the long-term accumulation of mitochondrial oxidative damage and for the extensive tissue damage seen in the absence of MnSOD [45, 46] . Figure 3 gives a reasonable description of mitochondrial O 2
THE PARADOX OF HYPOXIC H 2 O 2 PRODUCTION BY MITOCHONDRIA
•− production. However, mitochondrial ROS production is also reported to increase under conditions of very low [O 2 ], which is paradoxical and seems to contradict the dependence of mitochondrial O 2 •− production on [O 2 ] given in eqn (2). These hypoxic effects are seen in cultured cells when ambient O 2 is decreased from 21 % O 2 to 1-3 % O 2 [120, 121] . This corresponds to an equilibrium [O 2 ] of 10-20 μM, although the local [O 2 ] around mitochondria will be lower.
The discovery of increased mitochondrial ROS production during hypoxia arose from investigations of HIF-1 (hypoxiainducible factor-1), which plays a central role in the response of cells to hypoxia [122, 123] . HIF-1 is a heterodimer comprising HIF-1α and HIF-1β that translocates to the nucleus and there, in association with other proteins, initiates transcription of a number of genes in response to hypoxia [122, 123] . HIF-1α is constitutively expressed, but, under normoxia, it is rapidly hydroxylated on proline residues by PHD (prolyl hydroxylase), which uses 2-oxoglutarate and O 2 as substrates, marking HIF-1α for rapid degradation by the ubiquitin-proteasome system [122, 123] . When the [O 2 ] falls, HIF-1α is no longer degraded, allowing the HIF-1 heterodimer to form and induce the transcription of a series of hypoxia-sensitive genes. Further regulation of HIF-1 occurs because PHD activity is sensitive to H 2 O 2 , probably through reaction with non-haem iron in its active site [120, 121] . Thus the mitochondrial respiratory chain may act as an O 2 sensor, releasing H 2 O 2 under hypoxic conditions to decreases the activity of PHD, thereby stabilizing HIF-1α and modulating its response to hypoxia [120, 121] .
The evidence that hypoxia increases mitochondrial ROS production in cultured cells comes from measurements of cytosolic ROS using several different probes, and from showing that the effects of hypoxia-induced mitochondrial ROS on HIF-1 can be blocked by mitochondria-targeted antioxidants [120, 121, 124] . Further studies have shown that a functional respiratory chain is required, that loss of cytochrome c, or the Rieske FeS centre of complex III, abolishes this ROS signal [121, 125] , and that the direct addition of H 2 O 2 overcomes this blockade [126] . These studies have led to the proposal that the source of the ROS is complex III [121] , possibly a ubisemiquinone at the Q o site [126] efflux. Clearly, more work is required to unravel the mechanism of increased mitochondrial ROS production during hypoxia, but it remains an intriguing puzzle, and our understanding of mitochondrial ROS production will be incomplete until there is a satisfactory explanation for this phenomenon.
HOW MUCH O 2
•− DO MAMMALIAN MITOCHONDRIA PRODUCE IN VIVO?
To investigate the significance of mitochondrial O 2
•− production in oxidative damage and redox signalling, it is necessary to know how much O 2
•− is generated by mitochondria in vivo. The greatest rate of H 2 O 2 production by isolated mitochondria occurs during mode 2 when mitochondria have a high p, a reduced CoQ pool and are not making ATP. Under these conditions, ROS production is primarily by RET at complex I, and approx. 1-2 % of the O 2 consumed by isolated mitochondria under these conditions forms O 2
•− [1, 4, 27] . Since it was first published by Chance and colleagues [4, 12] , this value of 1-2 % of respiration going to O 2
•− has propagated through the literature and has been used erroneously to estimate mitochondrial O 2
•− production in vivo, even though the original authors made it clear that it only applied to particular experimental conditions [12] . Several factors make extrapolation of H 2 O 2 production by isolated mitochondria to the in vivo situation invalid. First, maximal O 2
•− production by isolated mitochondria occurs during RET using saturating levels of substrates such as succinate, which are at lower concentrations in vivo. When lower concentrations of succinate are used, approx. 0.4-0.8 % of respiration produces H 2 O 2 [57] , while use of the physiological substrate palmitoyl-CoA decreases H 2 O 2 production to approx. 0.15 % of respiration [24] , and, when glutamate/malate are used as substrates, H 2 O 2 production accounts for approx. 0.12 % of respiration [27] . Secondly, measurements on isolated mitochondria are generally made using air-saturated medium containing ∼ 200 μM O 2 . As mitochondrial O 2
•− production is probably proportional to [O 2 ] and the physiological [O 2 ] around mitochondria is approx. 10-50 μM, O 2
•− production may be 5-10-fold lower than for isolated mitochondria in the same state. The third and most important factor limiting extrapolation of in vitro O 2
•− production to the situation in vivo is that mitochondria in vivo are likely to be making ATP and will thus be operating in mode 3 with a lowered p and relatively oxidized NADH and CoQ pools. Consequently, their rates of H 2 O 2 efflux are negligible compared with modes 1 or 2. Therefore, although it is valid to say that 0.12-2 % of respiration goes to O 2
•− in vitro, these values cannot be extrapolated to the in vivo situation where mitochondrial O 2
•− production will be far, far lower. Allowing for these caveats, can we estimate roughly how much O 2
•− is produced by mitochondria in vivo? Unfortunately the answer at the moment is no, because we know little about basic mitochondrial function in vivo. For example, the proportion of time that mitochondria spend actively making ATP (i.e. in state 3) or with a high p and a low rate of ATP synthesis (i.e. in state 4) in vivo is not known. The proportion of mitochondria with a reduced NADH pool and whether RET occurs in vivo are also unclear. If, as is probable, mitochondria in vivo spend most of their time close to state 3, then we have very limited knowledge of how much O 2
•− production occurs in the matrix. Therefore, although there is considerable evidence for the accumulation of oxidative damage within mitochondria in vivo [3, 128] , from which we can infer that mitochondrial ROS production does occur, it is difficult to estimate the flux of mitochondrial O 2
•− that leads to this damage.
Although estimates of mitochondrial O 2
•− production as a proportion of respiration rate are not possible, can we infer from studies of mitochondria ex vivo the extent of O 2
•− production in vivo? The maximum O 2
•− production rate in vivo is proportional to the content of respiratory complexes such as complex I, and thus correlates with maximum respiration rate. However, as the actual O 2
•− production rate depends so closely on factors such as p and NADH/NAD + ratio, which vary markedly in vivo, it is not possible to say that changes in ROS production by mitochondria isolated from animals of different ages or hormonal status bear any relation to differences in mitochondrial ROS production in vivo. Is it at least possible to infer in vivo rates of mitochondrial O 2
•− production from direct measurements of ROS within living tissue? At the moment, the answer is also no, because quantification is challenging and currently there are no reliable estimates of mitochondrial O 2
•− production in vivo. A classic estimate of H 2 O 2 production was made in perfused liver where H 2 O 2 production by the whole organ was measured from changes in catalase compound I [129] . Approx. 80 nmol of H 2 O 2 /min per g of wet weight was produced in the tissue [127] , with about 12 nmol of H 2 O 2 /min per g of wet weight estimated to come from mitochondria [90] . However, one of the many assumptions made in this work was that mitochondrial H 2 O 2 production in situ was the same as for isolated mitochondria respiring on succinate, when they would have been producing H 2 O 2 by RET [90] . Therefore we know little about the actual flux of O 2
•− within mitochondria in vivo, about how it changes under different physiological circumstance, or about its quantititive importance relative to other sources of ROS. More work is required to develop methods to measure mitochondrial ROS production in vivo.
CONCLUSIONS

I have outlined the factors that lead to O 2
•− production within isolated mitochondria and have shown that there are two modes of high O 2
•− production, predominantly, but not exclusively, from complex I: by RET when the p is high and the CoQ pool is reduced, and from the FMN when the NADH/NAD + ratio is high (Figure 3 ). When mitochondria are actively making ATP, the rate of O 2
•− production is far lower and the sites of production are uncertain. This suggests that in vivo conditions leading to RET or an accumulation of NADH will favour O 2
•− production. However, the extent to which these situations arise in vivo is not known, and, at the moment, it is not possible to estimate the rate of mitochondrial O 2
•− production in vivo. Even so, the description given here of the factors underlying mitochondrial O 2
•− production will enable the design and interpretation of experiments to assess the physiological and pathological significance of mitochondrial ROS production in vivo. One area where such knowledge is vital is in the large number of pathologies where mitochondrial disruption leads to oxidative damage [3, 5] . This raises the possibility that better understanding of how mitochondria produce ROS will lead to the rational design of therapies to minimize mitochondrial oxidative damage [130] . Also important is the likelihood that ROS production by mitochondria is a redox signal integrating mitochondrial function with that of the rest of the cell [3, 9] . Redox signalling can occur by mitochondria releasing H 2 O 2 that modulates the activity of target proteins through the reversible oxidation of critical protein thiols [9, 131] , thus altering the activity of enzymes, kinases, phosphatases and transcription factors in mitochondria, the cytosol or the nucleus ( Figure 5 ). Although little is known currently about mitochondrial redox signalling, the description of ROS production developed here shows how it can occur and will prove useful in investigating this rapidly developing area. For example, mitochondrial H 2 O 2 efflux could act as a retrograde signal to the cell, reporting on mitochondrial p or the redox state of the NADH pool, and thus enable The production of H 2 O 2 from mitochondria is a potential redox signal. H 2 O 2 generated by mitochondria can reversibly alter the activity of proteins with critical protein thiols by modifying them to intra-or inter-protein disulfides, or to mixed disulfides with GSH. These modifications can occur on mitochondrial, cytosolic or nuclear enzymes, carriers or transcription factors, transiently altering their activities. The change in activity can be reversed by reducing the modified protein thiol by endogenous thiol reductants such as GSH or thioredoxin. As the extent of H 2 O 2 production from mitochondria will depend on factors such as p or the redox state of the NADH pool, it can act as a retrograde signal to the rest of the cell, reporting on mitochondrial status. This signal can then lead to the short-term modification of, for example, pathways supplying substrates to the mitochondria. Alternatively, longer-term modifications can occur through modifying redox-sensitive transcription factors that adjust the production of mitochondrial components. In addition, external signals may modify O 2 •− production by the respiratory chain by post-translational modification. Alteration of the activity of mitochondrial peroxidases could also modulate H 2 O 2 efflux from mitochondria to the rest of the cell. It is also possible that secondary redox signals, such as lipid peroxidation products derived from H 2 O 2 , could act as secondary redox signals.
the activity, transcription, translation, import or degradation of mitochondrial components to be adjusted accordingly. It is also likely that external signals can alter O 2
•− production through the post-translational modification of the respiratory chain, or by altering H 2 O 2 efflux from mitochondria by modulating the activity of matrix peroxidases such as peroxiredoxins. However, it is clear that to address these vital issues, better methods are required to assess mitochondrial p and the reduction potential of critical redox couples within mitochondria in vivo, and thus enable the tendency of mitochondria to produce O 2
•− to be inferred. Furthermore, techniques to measure the production of mitochondrial O 2
•− and H 2 O 2 directly in vivo also need to be developed. Such innovations are essential to understand the role of mitochondrial O 2
•− production in redox signalling and in pathological oxidative damage.
